Shandong WoHua Pharmaceutical Technology Co., Ltd. (hereinafter referred to as the "Company") held the seventh meeting of its eighth board of directors on January 19, 2026, via in-person and communication methods. The meeting notice was sent out on January 8, 2026, in written and electronic formats. A total of 9 directors were required to attend, and all 9 directors were present. The meeting was chaired by Mr. Zhao Bingxian. The convening of the meeting complies with the provisions of the Company Law and other relevant laws and regulations as well as the Articles of Association. After careful deliberation by the attending directors, the following resolutions were passed:
-
The meeting approved the proposal on the "2025 Annual Work Report of the Board of Directors" with 9 votes in favor, 0 votes against, and 0 abstentions.
-
The meeting approved the proposal on the "2025 Annual Report of the Board of Directors" with 9 votes in favor, 0 votes against, and 0 abstentions. The "2025 Annual Report of the Board of Directors of Shandong WoHua Pharmaceutical Technology Co., Ltd." is published on the Giant Tide Information Network (http://www.cninfo.com.cn) for investors to review. The independent directors Ms. Gao Mingqin, Mr. Wang Yuesheng, and Mr. Yu Junli submitted the "2025 Annual Performance Report of Independent Directors of Shandong WoHua Pharmaceutical Technology Co., Ltd." to the board and will present it at the 2025 annual shareholders' meeting. This proposal requires submission to the shareholders' meeting for review.
-
The meeting approved the proposal on the "2025 Internal Control Evaluation Report" with 9 votes in favor, 0 votes against, and 0 abstentions. The "2025 Internal Control Evaluation Report of Shandong WoHua Pharmaceutical Technology Co., Ltd." and the "Internal Control Implementation Self-Inspection Form" are published on the Giant Tide Information Network (http://www.cninfo.com.cn) for investors to review. This proposal has been reviewed and approved by the Audit Committee of the eighth board of directors at its first meeting in 2026.
-
The meeting approved the proposal on the "2025 Financial Settlement Report" with 9 votes in favor, 0 votes against, and 0 abstentions. The "2025 Financial Settlement Report of Shandong WoHua Pharmaceutical Technology Co., Ltd." is published in the Securities Times, China Securities Journal, and on the Giant Tide Information Network (http://www.cninfo.com.cn) for investors to review. This proposal requires submission to the shareholders' meeting for review.